The multi-billion dollarquestion is whether this positive trend will continue as we have seen slowdowns in the past only to see the curve explode upwards after a pause.
No one will be surprised when the results will show they are comparable, but thequestion will be: what strategies will the drug maker then use to keep the billion-dollar bonanza going?